Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

iBio (IBIO) Other Non-Current Assets (2016 - 2025)

iBio (IBIO) has disclosed Other Non-Current Assets for 11 consecutive years, with $200000.0 as the latest value for Q4 2025.

  • On a quarterly basis, Other Non-Current Assets rose 72.41% to $200000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $200000.0, a 72.41% increase, with the full-year FY2025 number at $26000.0, down 87.91% from a year prior.
  • Other Non-Current Assets was $200000.0 for Q4 2025 at iBio, roughly flat from $200000.0 in the prior quarter.
  • In the past five years, Other Non-Current Assets ranged from a high of $6.0 million in Q2 2022 to a low of $24000.0 in Q1 2021.
  • A 5-year average of $471650.0 and a median of $158000.0 in 2024 define the central range for Other Non-Current Assets.
  • Peak YoY movement for Other Non-Current Assets: surged 24883.33% in 2022, then crashed 95.78% in 2023.
  • iBio's Other Non-Current Assets stood at $1.2 million in 2021, then tumbled by 78.83% to $253000.0 in 2022, then plummeted by 80.24% to $50000.0 in 2023, then soared by 132.0% to $116000.0 in 2024, then soared by 72.41% to $200000.0 in 2025.
  • Per Business Quant, the three most recent readings for IBIO's Other Non-Current Assets are $200000.0 (Q4 2025), $200000.0 (Q3 2025), and $26000.0 (Q2 2025).